Stroes, Erik S.G.

FISHing for the Miracle of Eicosapentaenoic Acid

Kastelein, J. J. P., & Stroes, E. S. G. (2019) · New England Journal of Medicine

Fatty Acid Research and HealthLipoproteins and Cardiovascular Health

Cited by 74

Efficacy and Safety of Oral PCSK9 Inhibitor Enlicitide in Adults With Heterozygous Familial Hypercholesterolemia: A Randomized Clinical Trial

Ballantyne, C. M., Gellis, L., Tardif, J.-C., Banka, P., Navar, A. M., Asprusten, E. A., Scott, R., Stroes, E. S. G., Froman, S., Mendizabal, G., et al. (2026) · JAMA

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 68

Physical activity, metabolic syndrome, and coronary risk: the Epic-Norfolk prospective population study

Broekhuizen, L. N., Boekholdt, S. M., Arsenault, B. J., Despres, J., Stroes, E. S., Kastelein, J. J., Khaw, K., & Wareham, N. J. (2011) · European Journal of Cardiovascular Prevention & Rehabilitation

Physical Activity and HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 62

Olezarsen for Managing Severe Hypertriglyceridemia and Pancreatitis Risk

Marston, N. A., Bergmark, B. A., Alexander, V. J., Prohaska, T. A., Kang, Y. M., Moura, F. A., Zimerman, A., Waldman, E., Weinland, J., Murphy, S. A., et al. (2026) · New England Journal of Medicine

Lipid metabolism and disordersLipoproteins and Cardiovascular Health

Cited by 62

Combination statin-fibrate therapy: safety aspects

Franssen, R., Vergeer, M., Stroes, E. S. G., & Kastelein, J. J. P. (2009) · Diabetes, Obesity and Metabolism

Lipoproteins and Cardiovascular HealthPharmacogenetics and Drug Metabolism

Cited by 60

Network meta-analysis of randomized trials evaluating the comparative efficacy of lipid-lowering therapies added to maximally tolerated statins for the reduction of low-density lipoprotein cholesterol

Toth, P. P., Bray, S., Villa, G., Palagashvili, T., Sattar, N., Stroes, E. S. G., & Worth, G. M. (2022) · Journal of the American Heart Association

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 56

High density lipoprotein as a source of cholesterol for adrenal steroidogenesis: a study in individuals with low plasma HDL-C

Bochem, A. E., Holleboom, A. G., Romijn, J. A., Hoekstra, M., Dallinga-Thie, G. M., Motazacker, M. M., Hovingh, G. K., Kuivenhoven, J. A., & Stroes, E. S. G. (2013) · Journal of Lipid Research

Cholesterol and Lipid MetabolismLipoproteins and Cardiovascular Health

Cited by 56

Pharmaceutical Development and Safety Evaluation of a GMP-Grade Fucoidan for Molecular Diagnosis of Cardiovascular Diseases

Chauvierre, C., Aid-Launais, R., Aerts, J., Chaubet, F., Maire, M., Chollet, L., Rolland, L., Bonafé, R., Rossi, S., Bussi, S., et al. (2019) · Marine Drugs

Seaweed-derived Bioactive CompoundsRadiopharmaceutical Chemistry and Applications

Cited by 43

Omega-3 carboxylic acids in patients with severe hypertriglyceridemia: EVOLVE II, a randomized, placebo-controlled trial

Stroes, E. S. G., Susekov, A. V., de Bruin, T. W. A., Kvarnström, M., Yang, H., & Davidson, M. H. (2018) · Journal of Clinical Lipidology

Fatty Acid Research and HealthLipid metabolism and disorders

Cited by 38

apoB/apoA-I ratio and lp(a) associations with aortic valve stenosis incidence: insights from the EPIC-norfolk prospective population study

Zheng, K. H., Arsenault, B. J., Kaiser, Y., Khaw, K., Wareham, N. J., Stroes, E. S. G., & Boekholdt, S. M. (2019) · Journal of the American Heart Association

Lipoproteins and Cardiovascular HealthCardiac Valve Diseases and Treatments

Cited by 32

New Approaches for Targeting PCSK9: Small-Interfering Ribonucleic Acid and Genome Editing

Oostveen, R. F., Khera, A. V., Kathiresan, S., Stroes, E. S. G., Fitzgerald, K., Harms, M. J., Oakes, B. L., & Kastelein, J. J. P. (2023) · Arteriosclerosis, Thrombosis, and Vascular Biology

Lipoproteins and Cardiovascular HealthRNA Interference and Gene Delivery

Cited by 31

The effect of a diiodothyronine mimetic on insulin sensitivity in male cardiometabolic patients: a double-blind randomized controlled trial

van der Valk, F., Hassing, C., Visser, M., Thakkar, P., Mohanan, A., Pathak, K., Dutt, C., Chauthaiwale, V., Ackermans, M., Nederveen, A., et al. (2014) · PLoS ONE

Thyroid Disorders and TreatmentsDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 31

Acute Pancreatitis is Highly Prevalent and Complications can be Fatal in Patients with Familial Chylomicronemia: Results From a Survey of Lipidologist

Gaudet, D., Blom, D., Bruckert, E., Stroes, E., Kastelein, J., John, K., Malloy, M., Moulin, P., Retterstøļl, K., Hughes, S., et al. (2016) · Journal of Clinical Lipidology

Pancreatitis Pathology and TreatmentLipid metabolism and disorders

Cited by 30

Clinical profile of statin intolerance in the phase 3 GAUSS-2 Study

Cho, L., Rocco, M., Colquhoun, D., Sullivan, D., Rosenson, R. S., Dent, R., Xue, A., Scott, R., Wasserman, S. M., & Stroes, E. (2016) · Cardiovascular Drugs and Therapy

Lipoproteins and Cardiovascular HealthCancer, Lipids, and Metabolism

Cited by 30